Search results
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga via Yahoo Finance· 4 days agoModerna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent...
Moderna scores European victory over Pfizer and BioNTech in mRNA patent battle
Endpoints News· 4 days agoThe European Patent Office on Thursday handed a win to Moderna in a long-running patent battle with ...
Could Novavax Become the Next Moderna?
Motley Fool via Yahoo Finance· 5 days agoModerna fared well, dominating the vaccine market along with big pharma rival Pfizer, and bringing in as much as $18 billion in annual vaccine revenue.
Leaked Video of Mark Zuckerberg Discussing Vaccines Omits Context
Snopes via Yahoo News· 5 days agoIn Zuckerberg's full remarks on vaccine progress, which were not shared by Project Veritas, he...
Pfizer, AstraZeneca, Sanofi And Mainz Biomed To Uplevel Europe's Pharma Game
Benzinga via AOL· 6 days agoOn Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical...
Opinion | A Moderna Patent Bailout Would Set a Dangerous Precedent
The Wall Street Journal· 4 days agoThe Justice Department tries to use a wartime statute to make taxpayers pay for the company’s...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via AOL· 6 days agoThe U.S. contracted with AstraZeneca early in the pandemic for the delivery of 300 million doses of...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 3 days agoIs Novavax's stock a buy? This string of good news follows Novavax's announcement about three months...
S&P 500 Gains and Losses Today: Norwegian Cruise Soars on Guidance, Strategy Update
Investopedia· 2 days agoIn the days ahead, quarterly results from semiconductor giant Nvidia (NVDA) could provide a gauge of...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 2 days agoAfter all, Moderna was not the behemoth it is today. Until 2020-end, the company lacked a marketed...
